1-4 of 4
Carin Heringa, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact Of Prophylaxis With Defibrotide On The Occurrence Of Acute GvHD In Allogeneic HSCT

Selim Corbacioglu, MD, Simone Cesaro, MD, Maura Faraci, MD, Bernd Gruhn, Jaap J Boelens, MD, PhD, Ansgar Schulz, MD, Ingo Mueller, Jerry Stein, MD, Robert Wynn, MD, Johann Greil, MD, Karl-Walter Sykora, MD, Jacek Toporski, MD, PhD, Petr Sedlacek, Paul G. Schlegel, MD, Karoline Ehlert, MD, Christine Mauz-Koerholz, MD, Peter Bader, Elena Tudone, Maria Ballabio, MD, Carin Heringa, MD, Christina Peters
Journal: Blood
Blood (2013) 122 (21): 4591.
https://doi.org/10.1182/blood.V122.21.4591.4591
Published: 2013
Journal Articles

Results Of The Large Prospective Study On The Use Of Defibrotide (DF) In The Treatment Of Hepatic Veno-Occlusive Disease (VOD) In Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome - Updated Results Of a Treatment IND (T-IND) Expanded Access Protocol

Paul G. Richardson, MD, Angela R. Smith, MD, MS, Brandon M. Triplett, MD, Nancy A. Kernan, MD, Stephan A Grupp, MD, PhD, Sally Arai, MD, Paul R. Haut, MD, Paul L. Martin, MD, PhD, Heather J. Symons, MD, MHS, Leslie E. Lehmann, MD, Tiffany Simms-Waldrip, M.D., Alfred P. Gillio, III, MD, Biljana N. Horn, MD, Tsiporah B. Shore, Amrita Y. Krishnan, MD, Aleksandra Petrovic, MD, Ivan I. Kirov, MD, Ann E. Woolfrey, MD, Robert J. Greiner, MD, Shin Mineishi, MD, Michael Boyer, MD, Alison L. Hannah, MD, Joseph H. Antin, MD, Robin Hume, M.S., Valeria Bandiera, Carin Heringa, MD, Robert J. Soiffer, MD, Defibrotide Study Group
Journal: Blood
Blood (2013) 122 (21): 700.
https://doi.org/10.1182/blood.V122.21.700.700
Published: 2013
Journal Articles

Evaluation of Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Non-Stem Cell Transplant (non-SCT) Chemotherapy Patients (pts): Results From the Treatment IND (T-IND) Expanded Access Protocol and the Compassionate Use Program (CUP).

Paul G. Richardson, MD, Brandon M. Triplett, MD, Nancy A. Kernan, MD, Stephan A. Grupp, MD, PhD, Sally Arai, MD, Paul R. Haut, MD, Alfred P. Gillio, III, MD, Elena Tudone, Marco Sardella, PharmD, Valeria Bandiera, Carin Heringa, MD, Leslie E. Lehmann, MD, Robert J. Soiffer, MD, Dietger Niederwieser, MD, Defibrotide Study Group
Journal: Blood
Blood (2012) 120 (21): 3041.
https://doi.org/10.1182/blood.V120.21.3041.3041
Published: 2012
Journal Articles

Results of a Large Prospective Study On the Use of Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome – Updated Results of a Treatment IND (T-IND) Expanded Access Protocol

Paul G. Richardson, MD, Angela Smith, MD, MS, Nancy A. Kernan, MD, Stephan A. Grupp, MD, PhD, Sally Arai, MD, Brandon M. Triplett, MD, Paul R. Haut, MD, Kawah Chan, MD, Heather J. Symons, MD, MHS, Biljana N. Horn, MD, Alfred P. Gillio, III, MD, Michael Boyer, MD, Amrita Krishnan, MD, Leslie E. Lehmann, MD, Paul L. Martin, MD, PhD, Shin Mineishi, MD, Tsiporah B. Shore, MD, Tiffany Simms-Waldrip, M.D., Joseph H. Antin, MD, Alison L. Hannah, MD, Robin Hume, M.S., Elena Tudone, Carin Heringa, MD, Robert J. Soiffer, MD, Defibrotide Study Group
Journal: Blood
Blood (2012) 120 (21): 738.
https://doi.org/10.1182/blood.V120.21.738.738
Published: 2012